United States

- China

- Turkey

- Guatemala

- Ireland

- Israel

- Other

Total Revenue

96fe7c72170ae57c393973a874deb990f7514d5401f5784f3a4d89801434f513

Revenues (USD, thousands)

Cost of sales (USD, thousands)

Gross profit (USD, thousands)

Selling and marketing expenses (USD, thousands)

General and administrative expenses (USD, thousands)

Research and development expenses (USD, thousands)

Total operating expenses (USD, thousands)

Income (loss) from operations (USD, thousands)

Interest income (USD, thousands)

Income (loss) before income tax (USD, thousands)

Provision for (benefit from) income taxes (USD, thousands)

Net income (loss) (USD, thousands)

313357dd63474150c2566f662798f554f1cc87cfca4503fd5190cf7b2b70c632

Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories (USD, thousands)

Prepaid inventory (USD, thousands)

Other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Deferred tax asset (USD, thousands)

Operating lease right-of-use asset, net (USD, thousands)

Other noncurrent assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable and accrued expenses (USD, thousands)

Product warranties (USD, thousands)

Operating lease liability, current portion (USD, thousands)

Deferred revenue, current portion (USD, thousands)

Total current liabilities (USD, thousands)

Operating lease liability (USD, thousands)

Deferred revenue, net of current portion (USD, thousands)

Total liabilities (USD, thousands)

Common stock, $ 0.01 par value (USD, thousands)

Additional paid-in capital (USD, thousands)

Treasury stock (USD, thousands)

Retained earnings (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

065bc74067eb37b25e684ddea55cd6c0b08b84d680ef3c2fc4e6ce09d35e9bcd

Product Revenue

- Service Revenue

-- Recognized at a point in time

-- Recognized over time

09b5149a47c5cc6b6693d66d2199ad5cec449ec75dec544df89c155fb701e305

1f31a1240e9783d795a2cb9b3e2dc7aba3bd2ab3a9136df0e1f59aa44b55eb82

7b892528f449bbc57016b3a7dcd25685656ef7cefea542f5a3ea94e4ad9e84ed

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

cfed7738bfdd58d41ebf8473d5adbf83631abe0f3eb78208fa80d40e3c0b5670

Net cash provided by (used in) Operating activities (USD, thousands)

Net cash provided by (used in) Investing activities (USD, thousands)

Net cash provided by (used in) Financing activities (USD, thousands)

Net increase (decrease) in cash and cash equivalents (USD, thousands)

Income tax paid (USD, thousands)

Interest paid (USD, thousands)

Cash and cash equivalents - beginning of period (USD, thousands)

Cash and cash equivalents - end of period (USD, thousands)

81f5bd3b119e4d88e0d8f1c7000a31bb4d72ca7cdec63c789a95b5f201076767

Sensus Healthcare Inc (SRTS)

Financials